Literature DB >> 27033076

In Cell and In Vitro Assays to Measure PTEN Ubiquitination.

Amit Gupta1, Helene Maccario2, Nisha Kriplani1, Nicholas R Leslie3.   

Abstract

The lipid and protein tyrosine phosphatase, PTEN, is one of the most frequently mutated tumor suppressors in human cancers and is essential for regulating the oncogenic pro-survival PI3K/AKT signaling pathway. Because of its diverse physiological functions, PTEN has attracted great interest from researchers in multiple research fields. The functional diversity of PTEN demands a collection of delicate regulatory mechanisms, including transcriptional control and posttranslational mechanisms that include ubiquitination. Addition of ubiquitin to PTEN can have several effects on PTEN function, potentially regulating its stability, localization, and activity. In cell and in vitro ubiquitination assays are employed to study the ubiquitination-mediated regulation of PTEN. However, PTEN ubiquitination assays are challenging to perform and the data published from these assays has been of mixed quality. Here we describe protocols to detect PTEN ubiquitination in cultured cells expressing epitope tagged ubiquitin (in cell PTEN ubiquitination assay) and also using purified proteins (in vitro PTEN ubiquitination assay).

Entities:  

Keywords:  Cancer; PTEN; Phosphatase; Phosphoinositide; Tumor suppressor; Ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 27033076     DOI: 10.1007/978-1-4939-3299-3_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Controlling PTEN (Phosphatase and Tensin Homolog) Stability: A DOMINANT ROLE FOR LYSINE 66.

Authors:  Amit Gupta; Nicholas R Leslie
Journal:  J Biol Chem       Date:  2016-07-12       Impact factor: 5.157

2.  Microtopographical cues promote peripheral nerve regeneration via transient mTORC2 activation.

Authors:  Suzanne E Thomson; Chloe Charalambous; Carol-Anne Smith; Penelope M Tsimbouri; Theophile Déjardin; Paul J Kingham; Andrew M Hart; Mathis O Riehle
Journal:  Acta Biomater       Date:  2017-07-25       Impact factor: 8.947

3.  The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.

Authors:  Muhan Chen; Dawid G Nowak; Navneet Narula; Brian Robinson; Kaitlin Watrud; Alexandra Ambrico; Tali M Herzka; Martha E Zeeman; Matthias Minderer; Wu Zheng; Saya H Ebbesen; Kendra S Plafker; Carlos Stahlhut; Victoria M Y Wang; Lorna Wills; Abu Nasar; Mireia Castillo-Martin; Carlos Cordon-Cardo; John E Wilkinson; Scott Powers; Raffaella Sordella; Nasser K Altorki; Vivek Mittal; Brendon M Stiles; Scott M Plafker; Lloyd C Trotman
Journal:  J Cell Biol       Date:  2017-02-13       Impact factor: 10.539

4.  PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation.

Authors:  Amit Gupta; Sara Anjomani-Virmouni; Nikos Koundouros; Maria Dimitriadi; Rayman Choo-Wing; Adamo Valle; Yuxiang Zheng; Yu-Hsin Chiu; Sameer Agnihotri; Gelareh Zadeh; John M Asara; Dimitrios Anastasiou; Mark J Arends; Lewis C Cantley; George Poulogiannis
Journal:  Mol Cell       Date:  2017-03-16       Impact factor: 19.328

5.  Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway.

Authors:  Hai-Han Liao; Nan Zhang; Yan-Yan Meng; Hong Feng; Jing-Jing Yang; Wen-Jin Li; Si Chen; Hai-Ming Wu; Wei Deng; Qi-Zhu Tang
Journal:  Oxid Med Cell Longev       Date:  2019-12-06       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.